Sp571
SQUEEZING AWAY DISTAL ESOPHAGEAL SPASM
Date
May 7, 2023
Explore related products in the following collection:
Society: AGA
This session provides a deeper understanding of how and when to use our current state of the art tools for physiology testing. Audience members will appreciate the nuances of esophageal motility reading, when to order which pH test for reflux symptoms. This session will also focus on the currently identified esophageal motility disorders as per the Chicago Classification version 4.0. This will highlight potential therapeutic options for these disorders. Attendees will hear about non-achalasia motility disorders and focus on current studies that highlight treatment of Ineffective Esophageal Motility, Distal Esophageal Spasm, Achalasia, Esophagogastric Junction Outflow Obstruction, Absent Contractility, and Hypercontractile Esophagus.
This session provides a deeper understanding of how and when to use our current state of the art tools for physiology testing. Audience members will appreciate the nuances of esophageal motility reading, when to order which pH test for reflux symptoms. This session will also focus on the currently identified esophageal motility disorders as per the Chicago Classification version 4.0. This will highlight potential therapeutic options for these disorders. Attendees will hear about non-achalasia motility disorders and focus on current studies that highlight treatment of Ineffective Esophageal Motility, Distal Esophageal Spasm, Achalasia, Esophagogastric Junction Outflow Obstruction, Absent Contractility, and Hypercontractile Esophagus.
Presenter
Northwestern University Feinberg School of Medicine
Tracks
Related Products
LONGITUDINAL EFFECTS OF TREATMENT ON ESOPHAGEAL DYSMOTILITY IN EOSINOPHILIC ESOPHAGITIS
BACKGROUND: Novel treatment options for eosinophilic esophagitis (EoE) are needed. Previous studies have assessed mepolizumab (mepo), a monoclonal antibody against IL-5, with mixed results in EoE, and the efficacy of mepo in an adult and adolescent population has yet to be fully examined…
INTRODUCTION
SOCIETY: AGA
<i>THE SEVERITY OF REDUCED ESOPHAGEAL DISTENSIBILITY PARALLELS EOSINOPHILIC DISEASE DURATION</i>
Concomitant esophageal dysmotility can be present in up to 2/3 of patients with EoE and GERD. Esophageal dysmotility contribute to symptoms in these patients and can be a reason for a suboptimal response to therapy…
BASAL ZONE HYPEPLASIA IS DRIVEN BY SUPERBASAL CELLS THAT RETAIN STEM CELL IDENTITY PROGRAMS IN ADULT EOE
Background: Eosinophilic Esophagitis (EoE) is one of the most predominant causes of chronic esophageal symptoms in children. Pathological changes of the esophageal epithelium in EoE are characterized by basal cell hyperplasia (BCH), infiltration of eosinophils and elevated levels of cytokines (e.g…
